S4603 Gastrointestinal Manifestations of Systemic AL Amyloidosis

Introduction: Systemic amyloidosis is the extracellular deposition of abnormal proteins in various organs. Manifestations of gastrointestinal amyloidosis (GIA) include bleeding, pain, nausea, vomiting, or obstruction. GIA has a variety of endoscopic findings and may appear normal endoscopically. Given the non-specific nature of the symptoms and endoscopic appearance, diagnosing GIA can be challenging. We present a patient with GI manifestations of systemic AL amyloidosis. Case Description/Methods: A 70-year-old man with a recent diagnosis of non-ischemic heart failure initially presented for 3 months of nausea, vomiting, and epigastric pain. He was transferred after developing ventricular tachycardia and acute kidney injury (AKI). He underwent 2 upper endoscopies (EGD) 1 week apart at the outside facility, revealing progression of gastritis and duodenitis with severe pyloric stenosis on the second EGD. Biopsy revealed inflammation, but Congo red staining was not performed. EGD at our facility 1 week later showed thickened erythematous folds in the stomach and duodenum with rapidly progressive friability and erosions. In conjunction with a kappa/lambda ratio of 142, AKI, and newly diagnosed heart failure, a systemic infiltrative process was considered. He underwent endomyocardial biopsy, and both EGD and endomyocardial biopsies revealed amyloidosis. Bone marrow biopsy confirmed plasma cell neoplasm. Course was complicated by refractory ventricular arrhythmias resulting in cardiac arrest and comfort care. Discussion: GIA can represent a diagnostic dilemma due to a non-specific symptom complex, inconsistent endoscopic findings, and lack of a standard classification system. Early symptoms include weight loss, early satiety, nausea, or chronic diarrhea. GIA should remain on the differential in older patients with such symptoms. Further, there is a clear need to develop a classification system for endoscopic findings due to its variable appearance. In 2024, Song et al proposed a classification including 5 main types: protruding, granular, ulcerative, hemorrhagic, or nonspecific. Prospective studies are needed to assess its utility. In these patients, Congo red staining should be performed. Early recognition of symptoms and diagnosis of GIA can aid in the diagnosis of systemic amyloidosis, lead to earlier treatment initiation, and can prevent adverse outcomes.

Publication Details

Journal
The American Journal of Gastroenterology
Published
2025-10-01
DOI
https://doi.org/10.14309/01.ajg.0001145872.74423.49
Primary Topic
Amyloidosis: Diagnosis, Treatment, Outcomes
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

S4603 Gastrointestinal Manifestations of Systemic AL Amyloidosis

The American Journal of Gastroenterology
Amyloidosis: Diagnosis, Treatment, Outcomes
article

S4603 Gastrointestinal Manifestations of Systemic AL Amyloidosis

article en

Abstract

Introduction: Systemic amyloidosis is the extracellular deposition of abnormal proteins in various organs. Manifestations of gastrointestinal amyloidosis (GIA) include bleeding, pain, nausea, vomiting, or obstruction. GIA has a variety of endoscopic findings and may appear normal endoscopically. Given the non-specific nature of the symptoms and endoscopic appearance, diagnosing GIA can be challenging. We present a patient with GI manifestations of systemic AL amyloidosis. Case Description/Methods: A 70-year-old man with a recent diagnosis of non-ischemic heart failure initially presented for 3 months of nausea, vomiting, and epigastric pain. He was transferred after developing ventricular tachycardia and acute kidney injury (AKI). He underwent 2 upper endoscopies (EGD) 1 week apart at the outside facility, revealing progression of gastritis and duodenitis with severe pyloric stenosis on the second EGD. Biopsy revealed inflammation, but Congo red staining was not performed. EGD at our facility 1 week later showed thickened erythematous folds in the stomach and duodenum with rapidly progressive friability and erosions. In conjunction with a kappa/lambda ratio of 142, AKI, and newly diagnosed heart failure, a systemic infiltrative process was considered. He underwent endomyocardial biopsy, and both EGD and endomyocardial biopsies revealed amyloidosis. Bone marrow biopsy confirmed plasma cell neoplasm. Course was complicated by refractory ventricular arrhythmias resulting in cardiac arrest and comfort care. Discussion: GIA can represent a diagnostic dilemma due to a non-specific symptom complex, inconsistent endoscopic findings, and lack of a standard classification system. Early symptoms include weight loss, early satiety, nausea, or chronic diarrhea. GIA should remain on the differential in older patients with such symptoms. Further, there is a clear need to develop a classification system for endoscopic findings due to its variable appearance. In 2024, Song et al proposed a classification including 5 main types: protruding, granular, ulcerative, hemorrhagic, or nonspecific. Prospective studies are needed to assess its utility. In these patients, Congo red staining should be performed. Early recognition of symptoms and diagnosis of GIA can aid in the diagnosis of systemic amyloidosis, lead to earlier treatment initiation, and can prevent adverse outcomes.

The American Journal of GastroenterologyVol. 120(10S2)
Good health and well-being
Openalex Percentile: Top 39%
Amyloidosis: Diagnosis, Treatment, Outcomes
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

S4603 Gastrointestinal Manifestations of Systemic AL Amyloidosis · The American Journal of Gastroenterology (2025) | TGRS Research Map | TGRS